Salarius Pharmaceuticals Inc (SLRX): SLRX.......................................

Reply Private New

Next 10 Prev Next

glenn1919

Send PM Follow Ignore

Followers	205
Posts	37076
Boards Moderated	0
Alias Born	12/05/2003

glenn1919

Re: None

Tuesday, 07/23/2024 10:24:18 AM

Tuesday, July 23, 2024 10:24:18 AM

SLRX.........................................https://stockcharts.com/h-sc/ui?s=SLRX&p=W&b=5&g=0&id=p86431144783

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SLRX News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/01/2024 09:05:56 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/01/2024 09:04:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 08:01:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 08:04:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:09:41 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:10:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 09:03:14 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/25/2024 09:01:35 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/22/2024 09:25:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 09:13:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 12:15:44 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/17/2024 12:11:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 12:05:28 PM
Clinical Data on Salarius Pharmaceuticals’ Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting • GlobeNewswire Inc. • 06/17/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:04:58 PM
Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split • GlobeNewswire Inc. • 06/12/2024 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:17:10 PM
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/22/2024 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:02:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:29:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:25:02 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:13:07 PM
Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses • GlobeNewswire Inc. • 02/22/2024 01:00:00 PM
Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM

More SLRX News

InvestorsHub NewsWire

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM

Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover